comparemela.com

Safinamide Parkinson News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Newron provides H1 2022 results and updates on R&D and business activities

DGAP-News: Newron Pharmaceuticals S.p.A. / Key word(s): Half Year ReportNewron provides H1 2022 results and updates on R&D and business activities 15.09.2022 / 07:00 CET/CESTThe issuer is solely responsible for the content of this announcement.Milan, Italy, September 15, 2022, 7 am CET – Newron Pharmaceuticals.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.